Radiation Oncologist: Raymond Wynn, MD, FACR | Loyola Medicine

Raymond Wynn, MD, FACR

Raymond Wynn, MD, FACR

Radiation Oncology

Professor

Languages Spoken

English

Clinical Expertise

  • Bladder Cancer
  • Brain Tumor
  • Breast Cancer
  • Central Nervous System Malignancies (CNS)
  • Esophageal Cancer
  • Esophagus Cancer
  • Gastrointestinal Cancer
  • HDR/LDR Brachytherapy
  • Head And Neck Cancer
  • Kidney Cancer
  • Lung Cancer
  • Prostate Cancer
  • Radiosurgery
  • Rectal And Anal Cancer
  • Testicular Cancer

About Dr. Wynn

Interests

Medical Education

Medical School
Meharry Medical College
Residency
University of Rochester - Radiation Oncology
Fellowship

Board Certification

American Board of Radiology, Radiation Oncology

Research

  • Clinical implementation and evaluation of the Acuros dose calculation algorithm Yan, C.; Combine, A. G.; Bednarz, G.; Lalonde, R. J.; Hu, B.; Dickens, K.; Wynn, R.; Pavord, D. C.; Saiful Huq, M., Journal of Applied Clinical Medical Physics
  • Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial. Chun, SG; Hu, C; Choy, H; Komaki, RU; Timmerman, RD; Schild, SE; Bogart, JA; Dobelbower, MC; Bosch, W; Galvin, JM; Kavadi, VS; Narayan, S; Iyengar, P; Robinson, CG; Wynn, RB; Raben, A; Augspurger, ME; MacRae, RM; Paulus, R; Bradley, JD, Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617. Eaton, BR; Pugh, SL; Bradley, JD; Masters, G; Kavadi, VS; Narayan, S; Nedzi, L; Robinson, C; Wynn, RB; Koprowski, C; Johnson, DW; Meng, J; Curran, WJ, Journal of the National Cancer Institute
View All ResearchShow Less
  • Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. Movsas, B; Hu, C; Sloan, J; Bradley, J; Komaki, R; Masters, G; Kavadi, V; Narayan, S; Michalski, J; Johnson, DW; Koprowski, C; Curran, WJ; Garces, YI; Gaur, R; Wynn, RB; Schallenkamp, J; Gelblum, DY; MacRae, RM; Paulus, R; Choy, H, JAMA oncology
  • Counterpoint: Diversity and Inclusion: Works in Progress. Lightfoote, JB; Fielding, JR; Deville, C; Gunderman, RB; Morgan, GN; Pandharipande, PV; Duerinckx, AJ; Wynn, RB; Macura, KJ, Journal of the American College of Radiology : JACR
  • Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised two-by-two factorial phase 3 study., Bradley, JD; Paulus, R; Komaki, R; Masters, G; Blumenschein, G; Schild, S; Bogart, J; Hu, C; Forster, K; Magliocco, A; Kavadi, V; Garces, YI; Narayan, S; Iyengar, P; Robinson, C; Wynn, RB; Koprowski, C; Meng, J; Beitler, J; Gaur, R; Curran, W; Choy, H, The Lancet. Oncology
  • Improving diversity inclusion, and representation in radiology and radiation oncology part 1: why these matter., Lightfoote, JB; Fielding, JR; Deville, C; Gunderman, RB; Morgan, GN; Pandharipande, PV; Duerinckx, AJ; Wynn, RB; Macura, KJ, Journal of the American College of Radiology : JACR
  • Improving diversity inclusion, and representation in radiology and radiation oncology part 2: challenges and recommendations., Lightfoote, JB; Fielding, JR; Deville, C; Gunderman, RB; Morgan, GN; Pandharipande, PV; Duerinckx, AJ; Wynn, RB; Macura, KJ, Journal of the American College of Radiology : JACR